PDF(1424 KB)
Expression and prognostic value of triggering receptor expressed on myeloid cells-1 in patients with cirrhotic ascites and intra-abdominal infection
WEI Feng, YUE Xinyan, LIU Xiling, YAN Huimin, LIN Lin, HUANG Tao, PEI Yantao, SHAO Shixiang, DAI Erhei, YUAN Wenfang
PDF(1424 KB)
PDF(1424 KB)
Expression and prognostic value of triggering receptor expressed on myeloid cells-1 in patients with cirrhotic ascites and intra-abdominal infection
Objective To analyze the expression level of triggering receptor expressed on myeloid cells-1 (TREM-1) in serum and ascites of patients with cirrhotic ascites,and to investigate its correlation with clinical features and inflammatory markers and its role in the diagnosis of infection and prognostic evaluation. Methods A total of 110 patients with cirrhotic ascites who were hospitalized in The Fifth Hospital of Shijiazhuang from January 2019 to December 2020 were enrolled,and according to the presence or absence of intra-abdominal infection,they were divided into infection group with 72 patients and non-infection group with 38 patients. The patients with infection were further divided into improvement group with 38 patients and non-improvement group with 34 patients. Clinical data and laboratory markers were collected from all patients. Serum and ascites samples were collected,and ELISA was used to measure the level of TREM-1. The independent-samples t test was used for comparison of normally distributed continuous data between two groups; the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups,and the Kruskal-Wallis H test was used for comparison between multiple groups; the chi-square test was used for comparison of categorical data between two groups. A Spearman correlation analysis was used to investigate the correlation between indicators. A multivariate Logistic regression analysis was used to identify the influencing factors for the prognosis of patients with cirrhotic ascites and infection. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic and prognostic efficacy of each indicator,and the Delong test was used for comparison of the area under the ROC curve (AUC). Results The level of TREM-1 in ascites was significantly positively correlated with that in serum (r=0.50,P<0.001). Compared with the improvement group,the non-improvement group had a significantly higher level of TREM-1 in ascites (Z=-2.391,P=0.017) and serum (Z=-2.544,P=0.011),and compared with the non-infection group,the infection group had a significantly higher level of TREM-1 in ascites (Z=-3.420,P<0.001),while there was no significant difference in the level of TREM-1 in serum between the two groups (P>0.05). The level of TREM-1 in serum and ascites were significantly positively correlated with C-reactive protein (CRP),procalcitonin (PCT),white blood cell count,and neutrophil-lymphocyte ratio (r=0.288,0.344,0.530,0.510,0.534,0.454,0.330,and 0.404,all P<0.05). The ROC curve analysis showed that when PCT,CRP,and serum or ascitic TREM-1 were used in combination for the diagnosis of cirrhotic ascites with infection,the AUCs were 0.715 and 0.740,respectively. The multivariate Logistic regression analysis showed that CRP (odds ratio [OR]=1.019,95% confidence interval [CI]: 1.001 — 1.038,P=0.043) and serum TREM-1 (OR=1.002,95%CI: 1.000 — 1.003,P=0.016) were independent risk factors for the prognosis of patients with cirrhotic ascites and infection,and the combination of these two indicators had an AUC of 0.728 in predicting poor prognosis. Conclusion The level of TREM-1 is closely associated with the severity of infection and prognosis in patients with cirrhotic ascites,and combined measurement of TREM-1 and CRP/PCT can improve the diagnostic accuracy of infection and provide support for prognostic evaluation.
Liver Cirrhosis / Ascites / Infections / Triggering Receptor Expressed on Myeloid Cells-1 / Diagnosis / Prognosis
| [1] |
|
| [2] |
张馨月, 赵俊佳, 梁媛, 等. 髓样细胞触发受体与溃疡性结肠炎及其相关癌变的研究进展[J]. 中国免疫学杂志, 2023, 39(1): 211-214. DOI: 10.3969/j.issn.1000-484X.2023.01.035.
|
| [3] |
|
| [4] |
|
| [5] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
|
| [6] |
黎倍伶, 陈金军. 肝硬化腹腔感染的诊疗进展及挑战[J]. 临床肝胆病杂志, 2021, 37(4): 757-760. DOI: 10.3969/j.issn.1001-5256.2021.04.003.
|
| [7] |
张丽丽, 胡建华, 代欣璨, 等. 肝硬化腹水与肠黏膜屏障功能关系研究进展[J/CD]. 中国肝脏病杂志(电子版), 2023, 15(2): 23-27. DOI: 10.3969/j.issn.1674-7380.2023.02.005.
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
夏莹, 王颖, 何怀武, 等. 白细胞、降钙素原和超敏C反应蛋白在超高龄重症患者血流感染的诊断预测价值[J]. 中华医学杂志, 2019, 99(5): 365-369. DOI: 10.3760/cma.j.issn.0376-2491.2019.05.009.
|
| [16] |
杨平, 肖乐尧, 杨娜, 等. 降钙素原和凝血酶原活动度在肝衰竭合并感染预后中的评估价值[J]. 中华医院感染学杂志, 2022, 32(4): 531-534. DOI: 10.11816/cn.ni.2022-210509.
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
林晓宇, 李琛, 张婷, 等. 肝硬化门静脉高压症患者肠壁屏障功能的改变及其与易发感染的关系[J]. 中华肝脏病杂志, 2023, 31(1): 70-76. DOI: 10.3760/cma.j.cn501113-20220118-00031.
|
魏峰、岳鑫彦、闫会敏负责课题设计,资料分析,撰写论文;刘喜玲、林琳、黄涛、裴艳涛参与收集数据,修改论文;邵石祥、戴二黑、袁文芳负责拟定写作思路,指导撰写文章并最后定稿。
/
| 〈 |
|
〉 |